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Chondrolipoma in the Pelvic Cavity: 
a Case Report
A chondrolipoma is an extremely rare form of a benign mesenchymal tumor
containing mature cartilage and fatty tissue. Chondrolipomas may be found in
almost any part of the body, particularly in the connective tissue of the breast,
head and neck area, as well as in the skeletal muscle. However, to the best of our
knowledge, chondrolipomas located in the pelvic cavity have not been reported.
In this case report, we describe a case of a chondrolipoma in the pelvis, and
show that it has its own characteristic imaging findings, which included the com-
position of fatty tissue and calcification in most parts, as well as some focal areas
of chondroid tissue based on the CT and MR findings.
chondrolipoma is an extremely rare form of a benign mesenchymal
tumor containing mature cartilage and fatty tissue. Only a limited number
of chondrolipomas have been reported in the English literature.
According to these reports, chondrolipomas may be found almost anywhere in the
body, particularly in the connective tissue of the breast (1, 2), head and neck area (3,
4), as well as the skeletal muscle (5, 6). To the best of our knowledge, chondrolipomas
have not yet been reported in the pelvic cavity. Herein, we report a case of a
chondrolipoma in the pelvis, and describe its CT and MR findings.
CASE REPORT
A 55-year-old man, presented to our hospital, complained of a large pelvic mass,
which was found incidentally during a routine ultrasonography. The patient had no
history of abdominal or pelvic discomfort, nor any abdominal or pelvic surgery. In
addition, the patient had no relevant medical or family history except for diabetes
mellitus. Upon a digital rectal examination, a large mass with a stone-like hardness
was palpated at 5-6 cm above the anal verge. 
A single-phase helical CT (LightSpeed Ultra; GE Healthcare, Milwaukee, WI),
spanning the whole abdominopelvic cavity, was performed. The CT scanning parame-
ters included a beam collimation of 8 × 1.25 mm, a reconstruction interval of 1.25
mm, a pitch of 1.35, a rotation time of 0.8 seconds, a table speed of 13.5 mm/rotation,
120 kV and 160 mAs. Transverse CT images were obtained 70 seconds after the
intravenous injection of non-ionic contrast material (120 mL) at a rate of 3 mL/sec
(Ultravist 300; Bayer Schering Pharma, Berlin, Germany). Multi-planar reformatted
coronal images were reconstructed with the transverse images. The CT images
revealed a large, well-defined mass in the presacral space of the pelvic cavity, which
seemed to have a long stalk arising from the left gluteus medius muscle (Fig. 1A, B).
The stalk traversed along the surface of the left iliac bone, and proceeded through the
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Aleft sciatic foramen, and ended up connecting with the
mass. The CT attenuation generated an easily recognizable
mass, which was mainly composed of fatty tissue and
calcification, with most of the stalk becoming calcified. The
calcification in the mass was located peripherally in a linear
and rosary pattern. Some focal areas of intermediate
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Fig. 1. Chondrolipoma in pelvic cavity in 55-year-old man.
A, B. Transverse (A) and coronal (B) CT images show 8 cm, well-
defined mass occupying left side of presacral space of pelvic
cavity. Mass seems to have long stalk arising from left gluteus
medius muscle. Stalk traverses along surface of left iliac bone, and
further passes through left sciatic foramen, and finally connects
with mass. Mass is mainly composed of fatty tissue and calcifica-
tion. Note that calcifications in mass are located peripherally in
linear and rosary pattern, with most of stalk becoming calcified.
There are some focal areas of intermediate attenuation (arrows)
between fat tissue and calcification, which corresponds to
chondroid tissue histologically. 
C-E. Plain T1-weighted transverse (C), T2-weighted transverse
(D), T2-weighted coronal (E) MR images without fat suppression
show same mass mainly composed of hyperintense areas and
signal void areas on both T1- and T2-weighted images which
represent fatty tissue and calcification, respectively. Also seen are
focal areas of intermediate signal intensity (arrows), which
corresponded to chondroid tissue, as seen on CT images. 
Eattenuation were identified as a mixture between fatty
tissue and calcification, and occupied only a limited portion
of the mass. These areas were revealed to correspond to
chondroid tissue based on the histologic findings. MR
imaging (Horizon 1.5T; GE Healthcare, Milwaukee, WI)
was also performed with the use of a TORSO coil. On both
the T1-weighted (366/8, echo train length of zero, 5-mm
slice thickness, 2-mm gap, 256×192 matrix, 24-cm field of
view, 2 signal acquired, and sequence duration of 3-4
minutes) and T2-weighted (4300/84, echo train length of
ten, 5-mm slice thickness, 2-mm gap, 512×256 matrix, 24-
cm field of view, 2 signal acquired, and sequence duration
of 3-4 minutes) MR images, the mass was revealed to
mainly consist of the hyperintense and signal void areas
that represent fatty tissue and calcification, respectively
(Fig. 1C-E). Also seen are the focal areas of intermediate
signal intensity, as shown on the CT images. The gadolin-
ium-enhanced T1-weighted MR images obtained 30
seconds, 60 seconds, and 3 minutes after the intravenous
injection of contrast material (Gadovist; Bayer Schering
Pharma, Berlin, Germany), and the focal areas of the
intermediate signal intensity around the calcifications
observed at 30 and 60 seconds post-injection, became
isointense as the surrounding fat tissue at 3 minutes post-
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Fig. 1. Chondrolipoma in pelvic cavity in 55-year-old man.
F, G. Gadolinium-enhanced T1-weighted sagittal MR images without fat suppression, obtained 30 seconds (F) and 3 minutes (G) after
contrast injection, show same fatty mass with extensive calcifications. Note focal areas of intermediate signal intensity around calcifica-
tions (arrows) in F become isointense as with surrounding fatty tissue in G. This represents delayed enhancement. 
H. Cut surface of resected specimen shows 13 cm, yellowish mass with whitish area in upper portion, which inidcates that this mass is
composed of yellowish fatty tissue and whitish calcification. 
I. Photomicrograph of resected specimen indicates mature, fatty (black arrows), chondroid (white arrows), and fibrous (white
arrowheads) tissues (Hematoxylin & Eosin staining, ×100). These findings are consistent with chondrolipoma. 
HIinjection. This finding represented a delayed enhancement
(Fig. 1F, G). No fat suppression technique was applied on
our MR images.
The main mass was resected using a transabdominal
approach, whereas the stalk was removed through the
sciatic foramen. The surgical specimen consisted of a 13
cm, well-circumscribed, hard mass, with a severely
calcified external surface. The cut surface of the resected
specimen revealed a mass mixed with fatty tissue and
calcification (Fig. 1H). A histopathological examination
revealed that the mass was composed of lipoma with
chondroid metaplasia (Fig. 1I), as well as extensive
calcification within the chondroid tissue. In addition,
fibrous tissue was also intermingled within the chondroid
tissue. The final histological diagnosis was identified as a
chondrolipoma.
DISCUSSION
The term mesenchymoma was originally defined by
Stout (7) in 1948 to describe tumors containing at least two
mesenchymal tissues not normally found together. The
tumors can be classified as benign or malignant, and most
of the benign varieties have been called angiomyolipomas,
angiolipomas, chondrolipomas, osteolipomas, and other
names depending on the predominant tissue form in the
tumor. However, fibrous tissue is found in all mesenchy-
mal tumors, and is not counted as one of the elements (6).
Conversely, if a mesenchymal tumor is well-defined or
encapsulated and composed predominantly of one type of
mesenchymal tissue, along with one or more minor
element, the diagnosis should reflect the predominant
mesenchymal tissue (6). In our case, the diagnosis of a
chondrolipoma was appropriate, since the mass was
composed of a sufficiently high proportion of both fatty
tissue and extensively calcified chondroid tissue, though it
was well-defined and encapsulated. 
Two possible explanations for the pathogenesis of
cartilage and bone formation in benign mesenchymomas
have been proposed (5, 6, 8, 9). The first is that cartilage
arises from chondro-osseous metaplasias of adipose tissue,
presumably as a result of mechanical stress or trophic
disturbance. The close proximity or contact with bone and
a large joint, myxoid background, or a lipodystrophy-like
change, which are often associated with these tumors,
suggest a metaplastic process caused by a trophic distur-
bance or mechanical stress (8-10). The second is that the
cartilage may originate from multipotential cells in the
mesenchymoma. A previous immunohistochemical study
supported the explanation that the pattern of expression
for growth factor- , latent transforming growth factor-
binding protein-1 transforming, and bone morphogenetic
protein might play an important role in the transformation
of multipotential cells into the chondrolipoma (11).
Considering the proximity of the identified chondrolipoma
to the iliac bone of our case study, we agree with the first
explanation of chondroid-osseous metaplasia, which states
that the mass may be a result of a micro-trauma. 
Our mass occupied both the inside and outside of the
pelvic cavity; however, we could not clarify whether its
primary site was the pelvic cavity or the left buttock.
According to previously reported cases, chondrolipomas
were mostly found in the connective tissue and skeletal
muscle. The only reported case of an abdominal
chondrolipoma in a human occurred in the small bowel (8),
whereas a chondrolipoma was once documented in the
pelvic cavity of a dog (12). Considering these reports, we
thought that in our case, a chondrolipoma in the buttock
might be extended to the pelvic cavity through the sciatic
foramen, though the proportion of the mass in the pelvis
was greater than in the buttock. 
There are few reports pertaining to the imaging features
of chondrolipomas of various organs, with most cases
describing their MR features (5, 9, 13, 14). For these
reports, chondroid and fatty tissues were described as
intermediate and high signal intensity areas on T1-
weighted images, respectively. Both chondroid and fatty
tissues were identified as having a higher signal intensity
area than the surrounding muscle, whereas chondroid
tissue was depicted as having a higher signal intensity area
than fatty tissue on T2-weighted images. Signal void areas
corresponding to calcifications were only found in a small
portion of these reported cases. For the CT images, fatty
tissue was depicted as a low attenuation area (less than -30
Hounsfield units), whereas chondroid tissue was depicted
as an intermediate attenuation area. 
In our case, the mass was depicted to be primarily
composed of fatty tissue and calcification, which matched
the CT attenuation and MR signal intensity. Also, we
found that additional focal areas of intermediate attenua-
tion or signal intensity corresponded to chondroid tissue.
These findings were different from those described in
previously reported cases whereby, in our case, the
calcification was much more extensive, and the signal
intensity of chondroid tissue on the T2-weighted images
was intermediate. Moreover, we found extensive calcifica-
tion located peripherally  in a linear and rosary pattern. A
previous report also cited the observation of chondroid
tissue in a rosary pattern (9). Despite the very limited
number of reported cases, we propose that the rosary
pattern of either the chondroid tissue or calcification could
be a characteristic finding of chondrolipomas, and in our
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case, the calcification in a rosary pattern was likely a
consequence of the dystrophic change involving the
chondroid tissue. Moreover, the signal intensity of
chondroid tissue was intermediate on the T2-weighted
images, and could be explained by the presence of fibrous
tissue within the chondroid tissue (Fig. 1I), which reduced
the signal intensity of chondroid tissue below the fatty
tissue.
It is interesting that the focal areas of intermediate signal
intensity around the calcifications showed delayed
enhancement on the gadolinium-enhanced MR images.
Orui et al. (9) described the presence of enhancing foci
between the fatty tissue and chondroid tissue in a
chondrolipoma, without clarifying the histopathological
findings. Also, there have been no reports of chondrolipo-
mas with delayed enhancement. In our case, the exact
histopathology of the focal areas of delayed enhancement
was not substantiated. However, keeping in mind that the
location of these focal areas corresponded to chondroid
tissue, and that chondroid tissue is usually not enhanced,
even on the delayed phase, the delayed enhancement of
these focal areas may be attributed due to sufficient fibrous
tissue within the chondroid tissue.  
Despite the characteristic imaging findings of
chondrolipomas, fatty tumors such as lipomas or liposarco-
mas, which contain chondro-osseous differentiation, should
be included in the differential diagnosis (9). The treatment
of choice for chondrolipomas is surgical excision (5, 8, 14).
Local recurrence is rare, and may represent incomplete
removal (5, 8).
Conclusively, we experienced the only reported human
case of a chondrolipoma in the pelvic cavity, and found
that it had characteristic imaging features consistent with
fatty tissue and calcification, as well as the areas
corresponding to cartilage.
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